Robert W. King
Virology Department
Bristol-Myers Squibb Pharma
The Experimental Station
Wilmington
USA
Name/email consistency: high
- Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors. King, R.W., Klabe, R.M., Reid, C.D., Erickson-Viitanen, S.K. Antimicrob. Agents Chemother. (2002)
- A cell-based model of HCV-negative-strand RNA replication utilizing a chimeric hepatitis C virus/reporter RNA template. King, R.W., Zecher, M., Jeffries, M.W., Carroll, D.R., Parisi, J.M., Pasquinelli, C. Antivir. Chem. Chemother. (2002)
- Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine. King, R.W., Zecher, M., Jefferies, M.W. Antivir. Chem. Chemother. (2002)